Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-01

Clinical Trial Update: Antibiotics to Reduce Chorioamnionitis-Related Perinatal HIV Transmission [Phase 3]

View source ↗

Summary

Phase 3 trial update on antibiotics to reduce perinatal HIV transmission associated with chorioamnionitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 3 | Status: COMPLETED